AstraZeneca PLC
Change company Symbol lookup
Select an option...
AZN AstraZeneca PLC
PTON Peloton Interactive Inc
ETR Entergy Corp
ACMR ACM Research Inc
RGAGX American Funds The Growth Fund of America® Class R-6
ATRC AtriCure Inc
CTRA Coterra Energy Inc
CINF Cincinnati Financial Corp
ATOM Atomera Inc
IEAWW Infrastructure and Energy Alternatives 27 March 2023 *W EXP 03/27/2023
Go

Health Care : Pharmaceuticals | Large Cap Growth
Based in United Kingdom
Company profile

AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$65.82
Day's Change
-0.25 (-0.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
65.85
Day's Low
64.07
Volume
(Heavy Day)

Today's volume of 8,470,122 shares is on pace to be much greater than AZN's 10-day average volume of 6,279,512 shares.

8,470,122

Upcoming Events

AZN's fiscal year ends in December
There are no upcoming events for AZN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
April 29, 2022Q1 2022 Earnings Release$0.95$0.83 to $0.83$0.82
February 10, 2022Q4 2021 Earnings Release$0.84$0.69 to $0.77$0.535
November 12, 2021Q3 2021 Earnings Release$0.54$0.62 to $0.62$0.47
July 29, 2021Q2 2021 Earnings Release$0.45$0.43 to $0.43$0.48

Past Dividends

Ex-dividend dateAmountRecord datePay date
February 24, 2022$0.985February 25, 2022March 28, 2022
August 12, 2021$0.45August 13, 2021September 13, 2021

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.